About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Liver Safety Under Upfront Arimidex vs Tamoxifen

NCT00537771·16 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

Any age

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Histologically proven HR+ invasive breast cancer
Completed all primary surgery and chemotherapy (if given), and were candidates to receive hormonal adjuvant therapy
Postmenopausal woman

You may not be if

clinical evidence of metastatic disease
previous adjuvant hormonal therapy for breast cancer
liver diseases

The record

StatusCompleted

PhasePhase 4

Taking part384

StartedSep 2007

UpdatedJan 25, 2013

Conditions

Where16

Research Site
Fuzhou, Fujian, China
Research Site
Guangzhou, Guangdong, China
Research Site
Nanning, Guangxi, China

Clareo Health | Liver Safety Under Upfront Arimidex vs Tamoxifen